A citation-based method for searching scientific literature

Elizabeth C Mormino, Michael G Brandel, Cindee M Madison, Gil D Rabinovici, Shawn Marks, Suzanne L Baker, William J Jagust. Neuroimage 2012
Times Cited: 113







List of co-cited articles
957 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B.
William E Klunk, Henry Engler, Agneta Nordberg, Yanming Wang, Gunnar Blomqvist, Daniel P Holt, Mats Bergström, Irina Savitcheva, Guo-feng Huang, Sergio Estrada,[...]. Ann Neurol 2004
41

Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation.
Sylvia Villeneuve, Gil D Rabinovici, Brendan I Cohn-Sheehy, Cindee Madison, Nagehan Ayakta, Pia M Ghosh, Renaud La Joie, Samia Kate Arthur-Bentil, Jacob W Vogel, Shawn M Marks,[...]. Brain 2015
229
38

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
Reisa A Sperling, Paul S Aisen, Laurel A Beckett, David A Bennett, Suzanne Craft, Anne M Fagan, Takeshi Iwatsubo, Clifford R Jack, Jeffrey Kaye, Thomas J Montine,[...]. Alzheimers Dement 2011
35

Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B.
Julie C Price, William E Klunk, Brian J Lopresti, Xueling Lu, Jessica A Hoge, Scott K Ziolko, Daniel P Holt, Carolyn C Meltzer, Steven T DeKosky, Chester A Mathis. J Cereb Blood Flow Metab 2005
530
34

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade.
Clifford R Jack, David S Knopman, William J Jagust, Leslie M Shaw, Paul S Aisen, Michael W Weiner, Ronald C Petersen, John Q Trojanowski. Lancet Neurol 2010
29

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
Guy M McKhann, David S Knopman, Howard Chertkow, Bradley T Hyman, Clifford R Jack, Claudia H Kawas, William E Klunk, Walter J Koroshetz, Jennifer J Manly, Richard Mayeux,[...]. Alzheimers Dement 2011
28


PET Imaging of Tau Deposition in the Aging Human Brain.
Michael Schöll, Samuel N Lockhart, Daniel R Schonhaut, James P O'Neil, Mustafa Janabi, Rik Ossenkoppele, Suzanne L Baker, Jacob W Vogel, Jamie Faria, Henry D Schwimmer,[...]. Neuron 2016
603
27

Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers.
Clifford R Jack, David S Knopman, William J Jagust, Ronald C Petersen, Michael W Weiner, Paul S Aisen, Leslie M Shaw, Prashanthi Vemuri, Heather J Wiste, Stephen D Weigand,[...]. Lancet Neurol 2013
26

Distribution volume ratios without blood sampling from graphical analysis of PET data.
J Logan, J S Fowler, N D Volkow, G J Wang, Y S Ding, D L Alexoff. J Cereb Blood Flow Metab 1996
25

Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging.
Christopher C Rowe, Kathryn A Ellis, Miroslava Rimajova, Pierrick Bourgeat, Kerryn E Pike, Gareth Jones, Jurgen Fripp, Henri Tochon-Danguy, Laurence Morandeau, Graeme O'Keefe,[...]. Neurobiol Aging 2010
727
24

Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study.
Victor L Villemagne, Samantha Burnham, Pierrick Bourgeat, Belinda Brown, Kathryn A Ellis, Olivier Salvado, Cassandra Szoeke, S Lance Macaulay, Ralph Martins, Paul Maruff,[...]. Lancet Neurol 2013
23

Frequent amyloid deposition without significant cognitive impairment among the elderly.
Howard Jay Aizenstein, Robert D Nebes, Judith A Saxton, Julie C Price, Chester A Mathis, Nicholas D Tsopelas, Scott K Ziolko, Jeffrey A James, Beth E Snitz, Patricia R Houck,[...]. Arch Neurol 2008
730
21

Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects.
E C Mormino, J T Kluth, C M Madison, G D Rabinovici, S L Baker, B L Miller, R A Koeppe, C A Mathis, M W Weiner, W J Jagust. Brain 2009
514
21

11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment.
Clifford R Jack, Val J Lowe, Matthew L Senjem, Stephen D Weigand, Bradley J Kemp, Maria M Shiung, David S Knopman, Bradley F Boeve, William E Klunk, Chester A Mathis,[...]. Brain 2008
692
21


[11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease.
M A Mintun, G N Larossa, Y I Sheline, C S Dence, S Y Lee, R H Mach, W E Klunk, C A Mathis, S T DeKosky, J C Morris. Neurology 2006
822
19

Tau positron emission tomographic imaging in aging and early Alzheimer disease.
Keith A Johnson, Aaron Schultz, Rebecca A Betensky, J Alex Becker, Jorge Sepulcre, Dorene Rentz, Elizabeth Mormino, Jasmeer Chhatwal, Rebecca Amariglio, Kate Papp,[...]. Ann Neurol 2016
585
19

The Centiloid Project: standardizing quantitative amyloid plaque estimation by PET.
William E Klunk, Robert A Koeppe, Julie C Price, Tammie L Benzinger, Michael D Devous, William J Jagust, Keith A Johnson, Chester A Mathis, Davneet Minhas, Michael J Pontecorvo,[...]. Alzheimers Dement 2015
362
18

Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents.
Chester A Mathis, Yanming Wang, Daniel P Holt, Guo-Feng Huang, Manik L Debnath, William E Klunk. J Med Chem 2003
672
17

Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease.
Victor L Villemagne, Kerryn E Pike, Gaël Chételat, Kathryn A Ellis, Rachel S Mulligan, Pierrick Bourgeat, Uwe Ackermann, Gareth Jones, Cassandra Szoeke, Olivier Salvado,[...]. Ann Neurol 2011
570
17

Use of florbetapir-PET for imaging beta-amyloid pathology.
Christopher M Clark, Julie A Schneider, Barry J Bedell, Thomas G Beach, Warren B Bilker, Mark A Mintun, Michael J Pontecorvo, Franz Hefti, Alan P Carpenter, Matthew L Flitter,[...]. JAMA 2011
728
17


Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease.
Kerryn E Pike, Greg Savage, Victor L Villemagne, Steven Ng, Simon A Moss, Paul Maruff, Chester A Mathis, William E Klunk, Colin L Masters, Christopher C Rowe. Brain 2007
612
16

An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest.
Rahul S Desikan, Florent Ségonne, Bruce Fischl, Brian T Quinn, Bradford C Dickerson, Deborah Blacker, Randy L Buckner, Anders M Dale, R Paul Maguire, Bradley T Hyman,[...]. Neuroimage 2006
16

Clinical and biomarker changes in dominantly inherited Alzheimer's disease.
Randall J Bateman, Chengjie Xiong, Tammie L S Benzinger, Anne M Fagan, Alison Goate, Nick C Fox, Daniel S Marcus, Nigel J Cairns, Xianyun Xie, Tyler M Blazey,[...]. N Engl J Med 2012
16

The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
Marilyn S Albert, Steven T DeKosky, Dennis Dickson, Bruno Dubois, Howard H Feldman, Nick C Fox, Anthony Gamst, David M Holtzman, William J Jagust, Ronald C Petersen,[...]. Alzheimers Dement 2011
16

Considerations and code for partial volume correcting [18F]-AV-1451 tau PET data.
Suzanne L Baker, Anne Maass, William J Jagust. Data Brief 2017
119
16

Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer's disease.
Anne Maass, Susan Landau, Suzanne L Baker, Andy Horng, Samuel N Lockhart, Renaud La Joie, Gil D Rabinovici, William J Jagust. Neuroimage 2017
214
16

Imaging beta-amyloid burden in aging and dementia.
C C Rowe, S Ng, U Ackermann, S J Gong, K Pike, G Savage, T F Cowie, K L Dickinson, P Maruff, D Darby,[...]. Neurology 2007
792
15

Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease.
Milos D Ikonomovic, William E Klunk, Eric E Abrahamson, Chester A Mathis, Julie C Price, Nicholas D Tsopelas, Brian J Lopresti, Scott Ziolko, Wenzhu Bi, William R Paljug,[...]. Brain 2008
662
15

Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain.
N Tzourio-Mazoyer, B Landeau, D Papathanassiou, F Crivello, O Etard, N Delcroix, B Mazoyer, M Joliot. Neuroimage 2002
15

An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease.
Clifford R Jack, David S Knopman, Stephen D Weigand, Heather J Wiste, Prashanthi Vemuri, Val Lowe, Kejal Kantarci, Jeffrey L Gunter, Matthew L Senjem, Robert J Ivnik,[...]. Ann Neurol 2012
438
15

In vivo cortical spreading pattern of tau and amyloid in the Alzheimer disease spectrum.
Hanna Cho, Jae Yong Choi, Mi Song Hwang, You Jin Kim, Hye Mi Lee, Hye Sun Lee, Jae Hoon Lee, Young Hoon Ryu, Myung Sik Lee, Chul Hyoung Lyoo. Ann Neurol 2016
263
15

APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging.
John C Morris, Catherine M Roe, Chengjie Xiong, Anne M Fagan, Alison M Goate, David M Holtzman, Mark A Mintun. Ann Neurol 2010
616
14

β-Amyloid burden in healthy aging: regional distribution and cognitive consequences.
K M Rodrigue, K M Kennedy, M D Devous, J R Rieck, A C Hebrank, R Diaz-Arrastia, D Mathews, D C Park. Neurology 2012
267
14

Meta-analysis of amyloid-cognition relations in cognitively normal older adults.
Trey Hedden, Hwamee Oh, Alayna P Younger, Tanu A Patel. Neurology 2013
224
14


Defining imaging biomarker cut points for brain aging and Alzheimer's disease.
Clifford R Jack, Heather J Wiste, Stephen D Weigand, Terry M Therneau, Val J Lowe, David S Knopman, Jeffrey L Gunter, Matthew L Senjem, David T Jones, Kejal Kantarci,[...]. Alzheimers Dement 2017
350
13

Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years.
Heiko Braak, Dietmar R Thal, Estifanos Ghebremedhin, Kelly Del Tredici. J Neuropathol Exp Neurol 2011
12

Amyloid deposition is associated with impaired default network function in older persons without dementia.
Reisa A Sperling, Peter S Laviolette, Kelly O'Keefe, Jacqueline O'Brien, Dorene M Rentz, Maija Pihlajamaki, Gad Marshall, Bradley T Hyman, Dennis J Selkoe, Trey Hedden,[...]. Neuron 2009
702
12

18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial.
Rik Vandenberghe, Koen Van Laere, Adrian Ivanoiu, Eric Salmon, Christine Bastin, Eric Triau, Steen Hasselbalch, Ian Law, Allan Andersen, Alex Korner,[...]. Ann Neurol 2010
460
12

Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue.
Marta Marquié, Marc D Normandin, Charles R Vanderburg, Isabel M Costantino, Elizabeth A Bien, Lisa G Rycyna, William E Klunk, Chester A Mathis, Milos D Ikonomovic, Manik L Debnath,[...]. Ann Neurol 2015
429
12

NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.
Clifford R Jack, David A Bennett, Kaj Blennow, Maria C Carrillo, Billy Dunn, Samantha Budd Haeberlein, David M Holtzman, William Jagust, Frank Jessen, Jason Karlawish,[...]. Alzheimers Dement 2018
12

Simplified quantification of Pittsburgh Compound B amyloid imaging PET studies: a comparative analysis.
Brian J Lopresti, William E Klunk, Chester A Mathis, Jessica A Hoge, Scott K Ziolko, Xueling Lu, Carolyn C Meltzer, Kurt Schimmel, Nicholas D Tsopelas, Steven T DeKosky,[...]. J Nucl Med 2005
429
11

Amyloid-β associated cortical thinning in clinically normal elderly.
J Alex Becker, Trey Hedden, Jeremy Carmasin, Jacqueline Maye, Dorene M Rentz, Deepti Putcha, Bruce Fischl, Douglas N Greve, Gad A Marshall, Stephen Salloway,[...]. Ann Neurol 2011
249
11

The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals.
Bradford C Dickerson, Akram Bakkour, David H Salat, Eric Feczko, Jenni Pacheco, Douglas N Greve, Fran Grodstein, Christopher I Wright, Deborah Blacker, H Diana Rosas,[...]. Cereb Cortex 2009
649
11


Mild cognitive impairment: clinical characterization and outcome.
R C Petersen, G E Smith, S C Waring, R J Ivnik, E G Tangalos, E Kokmen. Arch Neurol 1999
11

Regional profiles of the candidate tau PET ligand 18F-AV-1451 recapitulate key features of Braak histopathological stages.
Adam J Schwarz, Peng Yu, Bradley B Miller, Sergey Shcherbinin, James Dickson, Michael Navitsky, Abhinay D Joshi, Michael D Devous, Mark S Mintun. Brain 2016
262
11


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.